Overview The News Click Therapeutics has received FDA 510(k) clearance for Motivista (CT-155), a smartphone-based prescription digital therapeutic indicated for treating negative symptoms of schizophr...
Browsing Tag: digital therapeutics schizophrenia
1
2
3
